Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,longTermInvestments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,issuanceOfStock,otherCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,priceHint,shortName,exchange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,exchangeDataDelayedBy,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,marketState,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry,address2
t0,TBH.DE,-1660327000.0,46732700,29947000,,87295000,,74866000,196794000,344527000,117786000,117786000,,-16798000,,,,12428000,633925000,516139000,289398000,-30491000,-1000,74867000,74866000,2470244000.0,654745000.0,3652232000.0,3375791000.0,64871000.0,7028023000.0,47830000.0,1310000.0,3155201000.0,757286000.0,2565874000.0,-481985000.0,50920000.0,324631000.0,508053000.0,8045000.0,83750000.0,-319735000.0,562202000.0,1378783000.0,401112000.0,2307490000.0,512284000.0,101340000.0,,-4438000.0,-20877000.0,-100000000.0,-131496000.0,3342000.0,-51249000.0,-2510000.0,-9427000.0,110551000.0,59435000.0,-15893000.0,-10074000.0,-12298000.0,-13093000.0,-3157000.0,-19276000.0,,,870730000.0,en-US,US,EQUITY,False,Delayed Quote,336.0,1630510548,0.0,338.0,338.0,336.0,29,-2.4929504,-0.007364852,15702187008,4.651163,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,TELEFLEX INC.  DL 1,GER,72.24,328.6857,7.3143005,0.022253176,338.49295,0,finmb_307430,XETRA,Teleflex Incorporated,USD,66,0,296.91998,7.5977473,39.08 - 368.0,-32.0,-0.08695652,39.08,368.0,1619699400,1635337800,1635769800,1.36,68.07131,0.004047619,4.936,REGULAR,0.0,336.0 - 338.0,336.0,334.0,340.0,de_market,1.19,,,368.0,39.08,328.69,338.49,66,,46.73M,,46.56M,0.37%,92.98%,,,,,,1.12,0.33%,1.36,0.40%,,5.76%,,"May 13, 2021",,,"Dec 31, 2020","Mar 28, 2021",10.98%,17.16%,3.97%,8.67%,2.54B,54.55,0.50%,1.32B,666.79M,279.52M,4.94,-42.90%,350.21M,7.49,2.47B,73.19,2.71,72.24,558.61M,458.5M,Value,19087-1603,Healthcare,14000,4,10,"Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.",Wayne,610 225 6800,PA,9,1609372800,1625097600,9,United States,http://www.teleflex.com,86400,8,550 East Swedesford Road,Medical Instruments & Supplies,Suite 400
t-1,TBH.DE,-1769255000.0,46732700,33769000,,76561000,,76131000,209885000,383554000,139900000,139900000,,-18721000,,,,-40000,711179000,571279000,327625000,-63339000,-470000,76601000,76131000,2519746000.0,652305000.0,3816102000.0,3336457000.0,50484000.0,7152559000.0,47812000.0,1752000.0,3096228000.0,777965000.0,2585966000.0,-459888000.0,49875000.0,375880000.0,540027000.0,8073000.0,100500000.0,-297298000.0,574547000.0,1422425000.0,395071000.0,2412013000.0,513196000.0,102520000.0,,4889000.0,-518957000.0,350000000.0,338945000.0,-13716000.0,28400000.0,-2510000.0,12954000.0,195458000.0,57274000.0,-15837000.0,32599000.0,9202000.0,-3035000.0,-6866000.0,-28325000.0,7817000.0,9355000.0,882398000.0,en-US,US,EQUITY,False,Delayed Quote,336.0,1630510548,0.0,338.0,338.0,336.0,29,-2.4929504,-0.007364852,15702187008,4.651163,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,TELEFLEX INC.  DL 1,GER,72.24,328.6857,7.3143005,0.022253176,338.49295,0,finmb_307430,XETRA,Teleflex Incorporated,USD,66,0,296.91998,7.5977473,39.08 - 368.0,-32.0,-0.08695652,39.08,368.0,1619699400,1635337800,1635769800,1.36,68.07131,0.004047619,4.936,REGULAR,0.0,336.0 - 338.0,336.0,334.0,340.0,de_market,1.19,,,368.0,39.08,328.69,338.49,66,,46.73M,,46.56M,0.37%,92.98%,,,,,,1.12,0.33%,1.36,0.40%,,5.76%,,"May 13, 2021",,,"Dec 31, 2020","Mar 28, 2021",10.98%,17.16%,3.97%,8.67%,2.54B,54.55,0.50%,1.32B,666.79M,279.52M,4.94,-42.90%,350.21M,7.49,2.47B,73.19,2.71,72.24,558.61M,458.5M,Value,19087-1603,Healthcare,14000,4,10,"Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.",Wayne,610 225 6800,PA,9,1609372800,1625097600,9,United States,http://www.teleflex.com,86400,8,550 East Swedesford Road,Medical Instruments & Supplies,Suite 400
t-2,TBH.DE,-1356564000.0,46732700,29218000,,115654000,,116587000,171673000,329324000,128433000,128433000,,-16652000,,,,-951000,628301000,499868000,298977000,-12779000,-18000,116605000,116587000,2228930000.0,639248000.0,3377085000.0,3236203000.0,48412000.0,6613288000.0,47697000.0,997000.0,3035934000.0,774636000.0,2363837000.0,-486676000.0,45681000.0,347480000.0,475247000.0,4915000.0,91750000.0,-323692000.0,548166000.0,1420561000.0,390476000.0,2035823000.0,526125000.0,96917000.0,6113000.0,22206000.0,-24265000.0,-285000000.0,-296218000.0,-2426000.0,-206055000.0,-2510000.0,7172000.0,107256000.0,56879000.0,-15826000.0,-3221000.0,-10297000.0,-3901000.0,-18422000.0,-23317000.0,8509000.0,9355000.0,945314000.0,en-US,US,EQUITY,False,Delayed Quote,336.0,1630510548,0.0,338.0,338.0,336.0,29,-2.4929504,-0.007364852,15702187008,4.651163,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,TELEFLEX INC.  DL 1,GER,72.24,328.6857,7.3143005,0.022253176,338.49295,0,finmb_307430,XETRA,Teleflex Incorporated,USD,66,0,296.91998,7.5977473,39.08 - 368.0,-32.0,-0.08695652,39.08,368.0,1619699400,1635337800,1635769800,1.36,68.07131,0.004047619,4.936,REGULAR,0.0,336.0 - 338.0,336.0,334.0,340.0,de_market,1.19,,,368.0,39.08,328.69,338.49,66,,46.73M,,46.56M,0.37%,92.98%,,,,,,1.12,0.33%,1.36,0.40%,,5.76%,,"May 13, 2021",,,"Dec 31, 2020","Mar 28, 2021",10.98%,17.16%,3.97%,8.67%,2.54B,54.55,0.50%,1.32B,666.79M,279.52M,4.94,-42.90%,350.21M,7.49,2.47B,73.19,2.71,72.24,558.61M,458.5M,Value,19087-1603,Healthcare,14000,4,10,"Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.",Wayne,610 225 6800,PA,9,1609372800,1625097600,9,United States,http://www.teleflex.com,86400,8,550 East Swedesford Road,Medical Instruments & Supplies,Suite 400
t-3,TBH.DE,-1507022000.0,46732700,29364000,,23291000,,11456000,191193000,278372000,57815000,57815000,,-15682000,,,,11848000,567034000,509219000,288662000,-34524000,13000,11443000,11456000,2260863000.0,624805000.0,3667728000.0,3097402000.0,75429000.0,6765130000.0,47595000.0,1100000.0,2935173000.0,790405000.0,2343561000.0,-510171000.0,46005000.0,553535000.0,456615000.0,5589000.0,83000000.0,-346815000.0,534383000.0,1544617000.0,374886000.0,2328791000.0,514755000.0,107140000.0,35701000.0,5039000.0,-10117000.0,25000000.0,7106000.0,5416000.0,147058000.0,-2510000.0,4727000.0,145342000.0,57346000.0,-15791000.0,-22529000.0,68988000.0,-7793000.0,15981000.0,-19368000.0,5690000.0,9986000.0,1088002000.0,en-US,US,EQUITY,False,Delayed Quote,336.0,1630510548,0.0,338.0,338.0,336.0,29,-2.4929504,-0.007364852,15702187008,4.651163,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,TELEFLEX INC.  DL 1,GER,72.24,328.6857,7.3143005,0.022253176,338.49295,0,finmb_307430,XETRA,Teleflex Incorporated,USD,66,0,296.91998,7.5977473,39.08 - 368.0,-32.0,-0.08695652,39.08,368.0,1619699400,1635337800,1635769800,1.36,68.07131,0.004047619,4.936,REGULAR,0.0,336.0 - 338.0,336.0,334.0,340.0,de_market,1.19,,,368.0,39.08,328.69,338.49,66,,46.73M,,46.56M,0.37%,92.98%,,,,,,1.12,0.33%,1.36,0.40%,,5.76%,,"May 13, 2021",,,"Dec 31, 2020","Mar 28, 2021",10.98%,17.16%,3.97%,8.67%,2.54B,54.55,0.50%,1.32B,666.79M,279.52M,4.94,-42.90%,350.21M,7.49,2.47B,73.19,2.71,72.24,558.61M,458.5M,Value,19087-1603,Healthcare,14000,4,10,"Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.",Wayne,610 225 6800,PA,9,1609372800,1625097600,9,United States,http://www.teleflex.com,86400,8,550 East Swedesford Road,Medical Instruments & Supplies,Suite 400
